Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 7.69K CHF in the quarter ending March 31, 2026, a decrease of -89.18%. This brings the company's revenue in the last twelve months to 109.50K, down -55.52% year-over-year. In the year 2025, Addex Therapeutics had annual revenue of 172.86K, down -57.84%.

• Revenue (ttm): 109.50K
• Revenue Growth: -55.52%
• P/S Ratio: 46.86
• Revenue / Employee: 36.50K
• Employees: 3
• Market Cap: 5.13M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	172.86K	-237.18K	-57.84%
Dec 31, 2024	410.04K	-1.21M	-74.64%
Dec 31, 2023	1.62M	172.23K	11.92%
Dec 31, 2022	1.44M	-1.71M	-54.18%
Dec 31, 2021	3.15M	-725.83K	-18.71%
Dec 31, 2020	3.88M	1.05M	36.89%
Dec 31, 2019	2.83M	-3.87M	-57.72%
Dec 31, 2018	6.70M	6.20M	1,240.82%
Dec 31, 2017	499.89K	373.24K	294.70%
Dec 31, 2016	126.65K	-348.97K	-73.37%
Dec 31, 2015	475.63K	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error